← All organizations
Highest phase reached
Phase 2
First clinical trial
Jul 1, 2014Last known activity
Jun 1, 2016
Defunct as of Oct 1, 2019
Timeline
2010s
- Jun 1, 2010
Shenzhen Hornetcorn Bio-technology Company, LTD— Founded
- Oct 1, 2019
Shenzhen Hornetcorn Bio-technology Company, LTD— Defunct
Drugs by trial phase (8 distinct, 11 trials)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Studied for
- Arthritis
- Arthritis, Rheumatoid
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Cartilage Diseases
- Cerebral Hemorrhage
- Colorectal Neoplasms
- Digestive System Diseases
- Digestive System Neoplasms
- Esophageal Neoplasms
- Fibrosis
- Gastrointestinal Diseases
- Gastrointestinal Neoplasms
- Hemorrhage
- Intestinal Neoplasms
- Liver Cirrhosis
- Lung Neoplasms
- Neoplasms
- Osteoarthritis
- Pneumoconiosis
- Stomach Neoplasms
Recent trials (11)
- NCT02790762Lead sponsorPhase 1Jun 1, 2016
- NCT02766348Lead sponsorPhase 2May 1, 2016
- NCT02652351Lead sponsorPhase 1Mar 1, 2016
- NCT02651441Lead sponsorPhase 1/Phase 2Feb 1, 2016
- NCT02643823Lead sponsorPhase 1Jan 1, 2016
- NCT02644863Lead sponsorPhase 2Dec 1, 2015
- NCT02487017Lead sponsorPhase 2May 1, 2015
- NCT02283879Lead sponsorPhase 1Mar 1, 2015
- NCT02291926Lead sponsorPhase 1Dec 1, 2014
- NCT02215837Lead sponsorPhase 2Aug 1, 2014
- NCT02202928Lead sponsorPhase 2Jul 1, 2014
Details
- Founded
- Shenzhen, CN Jun 1, 2010
- Last known activity
- Jun 1, 2016